← Back to Search

Bacterium

Oxalobacter Formigenes for Kidney Stones

N/A
Waitlist Available
Led By John Knight, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
History of any hepatic, renal, bowel or endocrine disease or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results
Timeline
Screening 3 weeks
Treatment Varies
Follow Up stool collected 48-96 hours post diet
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a common gut bacteria can help reduce oxalate in urine.

Who is the study for?
This trial is for healthy individuals who are not currently colonized with the bacterium O. formigenes and have no history of liver, kidney, bowel or endocrine diseases that could affect ion absorption or urinary excretion.
What is being tested?
The study tests if ingesting a small amount of O. formigenes can settle in human guts and change how much oxalate is passed in urine, which might help prevent kidney stones when following specific diets.
What are the potential side effects?
Since O. formigenes is considered harmless, significant side effects are not expected; however, changes in diet may cause digestive discomfort or alterations in bowel habits.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have liver, kidney, bowel, or hormone diseases affecting drug processing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~stool collected 48-96 hours post diet
This trial's timeline: 3 weeks for screening, Varies for treatment, and stool collected 48-96 hours post diet for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measurement of urinary oxalate by ion chromatography mass spectrometry
Secondary study objectives
Measurement of stool oxalate by ion chromatography mass spectrometry

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Oxalobacter formigenesExperimental Treatment1 Intervention
Subjects will ingest a live preparation of O.formigenes
Group II: Moderately high oxalate/low calcium dietExperimental Treatment1 Intervention
Subjects not colonized with Oxalobacter formigenes will be equilibrated to a moderately high oxalate/ low calcium oxalate diet to enhance dietary oxalate absorption. Subjects will be colonized with Oxalobacter formigenes(Intervention). Following colonization with Oxalobacter formigenes, urinary oxalate will be measured to determine the impact of colonization.
Group III: Low Oxalate DietExperimental Treatment1 Intervention
Subjects not colonized with Oxalobacter formigenes will be equilibrated to a low oxalate diet to determine baseline oxalate values in urine . Subjects will be colonized with Oxalobacter formigenes (Intervention). Following colonization with Oxalobacter formigenes, urinary oxalate will be measured to determine the impact of colonization.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,342,750 Total Patients Enrolled
14 Trials studying Kidney Stones
778 Patients Enrolled for Kidney Stones
John Knight, PhD4.614 ReviewsPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham
1 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Kidney Stones
136 Patients Enrolled for Kidney Stones
5Patient Review
Dr. Knight was very thorough in his explanation of the hip replacement procedure I was considering. He was transparent about what to expect and I'm happy to say that everything went as he said it would. I would recommend him to anyone seeking an orthopaedic surgeon.

Media Library

Oxalobacter formigenes (Bacterium) Clinical Trial Eligibility Overview. Trial Name: NCT03752684 — N/A
Kidney Stones Research Study Groups: Low Oxalate Diet, Moderately high oxalate/low calcium diet, Oxalobacter formigenes
Kidney Stones Clinical Trial 2023: Oxalobacter formigenes Highlights & Side Effects. Trial Name: NCT03752684 — N/A
Oxalobacter formigenes (Bacterium) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03752684 — N/A
~3 spots leftby Nov 2025